The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives

References

• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: A global burden of disease 2010 study. Circulation. 2014;129:837–847.
   PubMed Web of Science ®Google Scholar
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med. 1994:1449–1457.
   PubMedGoogle Scholar
• Blackshear JLOJA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–759.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart R. J Am Coll Cardiol. 2019;74:104–132.
   PubMed Web of Science ®Google Scholar
• Meier B, Chairperson E, Blaauw Y, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace. 2014:1397–1416. DOI:10.1093/europace/euu174.
   PubMed Web of Science ®Google Scholar
• Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention. 2016;11:1170–1179.
   PubMed Web of Science ®Google Scholar
• Landmesser U, Tondo C, Camm J, et al. Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry. EuroIntervention. 2018;14:e590–e597.
   PubMed Web of Science ®Google Scholar
• Huang H, Liu Y, Xu Y, et al. Percutaneous Left atrial appendage closure with the LAmbre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study. JACC Cardiovasc Interv. 2017;10:2188–2194.
   PubMed Web of Science ®Google Scholar
• Bellmann B, Schnupp S, KÜhnlein P, et al. Left atrial appendage closure with the new Occlutech® device: first in man experience and neurological outcome. J Cardiovasc Electrophysiol. 2017;28:315–320.
   PubMed Web of Science ®Google Scholar
• Kim JS, Lee SG, Bong SK, et al. Preclinical assessment of a modified Occlutech left atrial appendage closure device in a canine model. Int J Cardiol. 2016;221:413–418.
   PubMed Web of Science ®Google Scholar
• Asmarats L, Masson JB, Pagnotta PA, et al. Percutaneous left atrial appendage closure with the ultraseal device: insights from the initial multicenter experience. JACC Cardiovasc Interv. 2018;11:1932–1941.
   PubMed Web of Science ®Google Scholar
• Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12.
   PubMed Web of Science ®Google Scholar
• Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation a randomized clinical trial. JAMA. 2014;312:1988–1998.
   PubMed Web of Science ®Google Scholar
• Reddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70:2964–2975.
   PubMed Web of Science ®Google Scholar
• Boersma LVA, Schmidt B, Betts TR, et al. EWOLUTION: design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology. Catheter Cardiovasc Interv. 2016;88:460–465.
   PubMed Web of Science ®Google Scholar
• Boersma LV, Ince H, Kische S, et al. Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology. Circ Arrhythmia Electrophysiol. 2019;12:1–13.
   Web of Science ®Google Scholar
• Boersma LVA, Schmidt B, Betts TR, et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016;37:2465–2474.
   PubMed Web of Science ®Google Scholar
• Reddy VY, Akehurst RL, Gavaghan MB, et al. Cost-effectiveness of left atrial appendage closure for stroke reduction in atrial fibrillation: analysis of pooled, 5-year, long-term data. J Am Heart Assoc. 2019;8:2–11.
   Web of Science ®Google Scholar
• Schwartz RS, Holmes DR, Van Tassel RA, et al. Left atrial appendage obliteration. JACC Cardiovasc Interv. 2010;3:870–877.
   PubMed Web of Science ®Google Scholar
• Kar S, Hou D, Jones R, et al. Impact of watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model. JACC Cardiovasc Interv. 2014;7:801–809.
   PubMed Web of Science ®Google Scholar
• Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–542.
   PubMed Web of Science ®Google Scholar
• Bergmann MW, Betts TR, Sievert H, et al. Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry. 2017; 877–884.
   Google Scholar
• Søndergaard L, Wong YH, Reddy VY, et al. Propensity-matched comparison of oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with WATCHMAN. JACC Cardiovasc Interv. 2019;12:1055–1063.
   PubMed Web of Science ®Google Scholar
• Price MJ, Reddy VY, Valderrábano M, et al. Bleeding outcomes after left atrial appendage closure compared with long-term warfarin a pooled, patient-level analysis of the WATCHMAN randomized trial experience. JACC Cardiovasc Interv. 2015;8:1925–1932.
   PubMed Web of Science ®Google Scholar
• Lempereur M, Aminian A, Freixa X, et al. Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv. 2017;90:E111–E121.
   PubMed Web of Science ®Google Scholar
• Korsholm K, Nielsen KM, Jensen JM, et al. Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy. EuroIntervention. 2017;12:2075–2082.
   PubMed Web of Science ®Google Scholar
• Shamim S, Magalski A, Chhatriwalla AK, et al. Transesophageal echocardiographic diagnosis of a WATCHMAN left atrial appendage closure device thrombus 10 years following implantation. Echocardiography. 2017;34:128–130.
   PubMed Web of Science ®Google Scholar
• Dukkipati SR, Kar S, Holmes DR, et al. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018;138:874–885.
   PubMed Web of Science ®Google Scholar
• Fauchier L, Cinaud A, Brigadeau F, et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71(14):1528–1536.
   Google Scholar
• Aminian A, Schmidt B, Mazzone P, et al. Incidence, characterization, and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER amulet observational study. JACC Cardiovasc Interv. 2019. DOI:10.1016/j.jcin.2019.02.003.
   Web of Science ®Google Scholar
• Alkhouli M, Busu T, Shah K, et al. Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis. JACC Clin Electrophysiol. 2018. DOI:10.1016/j.jacep.2018.09.007.
   Google Scholar
• Salazar CA, Del Aguila D, Cordova EG. Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation. Cochrane Database Syst Rev. [Internet]. 2014. DOI:10.1002/14651858.CD009893.pub2.
   Web of Science ®Google Scholar
• Chatterjee S, Sardar P, Giri JS, et al. Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients. Mayo Clin Proc. 2014;89:896–907.
   PubMed Web of Science ®Google Scholar
• Shore S, Ho PM, Lambert-Kerzner A, et al. Site-level variation in and practices associated with dabigatran adherence. JAMA. 2015;313:1443–1450.
   PubMed Web of Science ®Google Scholar
• Granger CB, Alexander JH, McMurray J. Apixaban versus warfarin in patients with atrial fibrillation christopher. N Engl J Med. 2011;365:981–992.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Phil D, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–1149.
   PubMed Web of Science ®Google Scholar
• Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman device in patients with atrial fibrillation: a PROTECT AF (percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients wit. J Am Coll Cardiol. Internet]. 2012 [cited 2016 May 30];59:923–929. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22381428
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;2016:1609–1678.
   Web of Science ®Google Scholar
• Wintgens L, Romanov A, Phillips K, et al. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry. EP Eur. 2018;20:1783–1789.
   PubMed Web of Science ®Google Scholar
• Phillips KP, Romanov A, Artemenko S, et al. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry. EP Eur. 2020;22:225–231.
   PubMed Web of Science ®Google Scholar
• Liu J, Xia Y, Zhang H, et al. Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation. Herz. [Internet]. 2020. DOI:10.1007/s00059-019-04880-4.
   Web of Science ®Google Scholar
• Liu F, Lin W, Liao H, et al. Mid-term outcomes of concomitant left atrial appendage closure and catheter ablation for non-valvular atrial fibrillation: a multicenter registry. Heart Vessels. 2019;34:860–867.
   PubMed Web of Science ®Google Scholar
• Fassini G, Conti S, Moltrasio M, et al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. Internet]. 2016 [cited 2017 Oct 25];18:1705–1710. Available from: https://academic.oup.com/europace/article-lookup/doi/10.1093/europace/euw007
   PubMed Web of Science ®Google Scholar
• Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109–118.
   PubMed Web of Science ®Google Scholar
• Lakkireddy D, Sridhar Mahankali A, Kanmanthareddy A, et al. Left atrial appendage ligation and ablation for persistent atrial fibrillation. JACC Clin Electrophysiol. 2015;1:153–160.
   PubMedGoogle Scholar
• Kim YG, Shim J, Oh SK, et al. Electrical isolation of the left atrial appendage increases the risk of ischemic stroke and transient ischemic attack regardless of postisolation flow velocity. Hear Rhythm. 2018;15:1746–1753.
   PubMed Web of Science ®Google Scholar
• Mentias A, Saad M, Girotra S, et al. Impact of pre-existing and new-onset atrial fibrillation on outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12:2119–2129.
   PubMed Web of Science ®Google Scholar
• Schade A, Kerber S, Hamm K. Two in a single procedure: combined approach for MitraClip implantation and left atrial appendage occlusion using the watchman device. J Invasive Cardiol. 2014;26:5–7.
   Web of Science ®Google Scholar
• Wong Y-H, Cesna S, Sawaya FJ, et al. Percutaneous left atrial appendage closure following transcatheter aortic valve replacement: results from the ATTRACTIVE study. Struct Hear. 2018. DOI:10.1080/24748706.2018.1516913.
   PubMedGoogle Scholar
• Francisco ARG, Infante de Oliveira E, Nobre MM, et al. Combined MitraClip implantation and left atrial appendage occlusion using the Watchman device: a case series from a referral center. Rev Port Cardiol. 2017;36:525–532.
   PubMedGoogle Scholar
• Maarse M, Wintgens L, N M K, et al. Feasibility of paediatric probes in transoesophageal echocardiographic guiding of left atrial appendage closure in adults. EuroIntervention. 2020. Internet. DOI:10.4244/EIJ-D-19-00943.
   PubMedGoogle Scholar
• Berti S, Paradossi U, Meucci F, et al. Periprocedural intracardiac echocardiography for left atrial appendage closure: a dual-center experience. JCIN. 2014;7:1036–1044.
   Google Scholar
• Budge LP, Shaffer KM, Moorman JR, et al. Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT. J Interv Card Electrophysiol. 2008;23:87–93.
   PubMed Web of Science ®Google Scholar
• Clemente A, Avogliero F, Berti S, et al. Multimodality imaging in preoperative assessment of left atrial appendage transcatheter occlusion with the Amplatzer Cardiac Plug. Eur Heart J Cardiovasc Imaging. 2015;16:1276–1287.
   PubMed Web of Science ®Google Scholar
• Wang DD, Eng M, Kupsky D, et al. Application of 3-dimensional computed tomographic image guidance to watchman implantation and impact on early operator learning curve: single-center experience. JACC Cardiovasc Interv. 2016;9:2329–2340.
   Web of Science ®Google Scholar
• Coisne A, Pilato R, Brigadeau F, et al. Percutaneous left atrial appendage closure improves left atrial mechanical function through Frank–Starling mechanism. Hear Rhythm. 2017;14:710–716.
   PubMed Web of Science ®Google Scholar
• Fan Y, Yang F, Cheung GSH, et al. Device sizing guided by echocardiography-based three-dimensional printing is associated with superior outcome after percutaneous left atrial appendage occlusion. J Am Soc Echocardiogr. 2019;32:708–719.e1.
   Web of Science ®Google Scholar
• Eng MH, Wang DD, Greenbaum AB, et al. Prospective, randomized comparison of 3-dimensional computed tomography guidance versus TEE data for left atrial appendage occlusion (PRO3DLAAO). Catheter Cardiovasc Interv. 2018;92:401–407.
   Web of Science ®Google Scholar